| Literature DB >> 36077683 |
Akihisa Kato1, Hiroyuki Kato2, Itaru Naitoh1, Kazuki Hayashi1, Michihiro Yoshida1, Yasuki Hori1, Kenta Kachi1, Go Asano1, Hidenori Sahashi1, Tadashi Toyohara1, Kayoko Kuno1, Yusuke Kito1, Satoru Takahashi2, Hiromi Kataoka1.
Abstract
Histological evidence is essential for diagnosing malignant biliary strictures. However, conventional brush cytology remains the primary method used worldwide, despite its low diagnostic sensitivity and accuracy, as it is technically easy, rapid, and cost-effective. The aim of this study was to evaluate the diagnostic performance of a recently introduced endoscopic scraper, the simplicity of which is comparable to that of a conventional brush, by comparing diagnostic yields and the number of collected cells. The sensitivity of the endoscopic scraper when using the cell block technique was significantly higher than when using brush cytology or a brush with the cell block technique (53.6% vs. 30.9%, p < 0.001; 53.6% vs. 31.6%, p = 0.024, respectively). Quantitative digital image analysis of cell block sections revealed that the median number of cells obtained with the endoscopic scraper was significantly higher than when using the brush (1917 vs. 1014 cells, p = 0.042). Furthermore, seven cases (8.3%; 7/84) were diagnosed by immunohistochemical analysis of the cell block section obtained from the endoscopic scraper. Given its simplicity and greater capacity for sample acquisition, use of the endoscopic scraper in conjunction with the cell block technique could replace brush cytology for the histological diagnosis of malignant biliary strictures.Entities:
Keywords: biliary strictures; cell block; conventional brush; endoscopic scraper
Year: 2022 PMID: 36077683 PMCID: PMC9454915 DOI: 10.3390/cancers14174147
Source DB: PubMed Journal: Cancers (Basel) ISSN: 2072-6694 Impact factor: 6.575
Figure 1Epithelial cell count analysis on cell block sections. (A,B): histological findings of scraper group (A) and brush group (B) in low-power field. The areas with epithelial components are circled in red. The areas circled by the green line were excluded due to the presence of necrotic tissue and inflammatory cells. (C,D): histological findings in high-power field (C) and analysis image of Aperio CS2 (D). Yellow-colored nuclei; only the nuclei of the epithelial component were measured. (E): comparison of the median numbers of cells obtained by each device; *, p < 0.05.
Clinical characteristics.
| Characteristic of the Patients ( | |
|---|---|
| Sex, | 301/134 |
| Age (years), median (range) | 73 (23–98) |
| Final diagnosis | |
| Malignant disease, | 328 (75.4%) |
| Bile duct cancer, | 137 |
| Pancreatic cancer, | 125 |
| Gallbladder cancer, | 28 |
| Others, | 38 |
| Benign disease, | 107 (24.6%) |
| IgG4-related sclerosing cholangitis, | 50 |
| Primary sclerosing cholangitis, | 15 |
| Others, | 42 |
| Sampling method | |
| Scraper (Trefle) + cell block, | 101 (23.2%) |
| Brush cytology, | 188 (43.2%) |
| Brush + cell block, | 55 (12.6%) |
| Forceps biopsy, | 326 (74.9%) |
Diagnostic yield of each sampling method.
| Scraper Cell Block | Brush Cytology | Brush Cell Block | Forceps Biopsy | |
|---|---|---|---|---|
| Sensitivity % ( | 53.6 (45/84) | 30.9 (46/149) | 31.6 (12/38) | 62.3 (157/252) |
| Bile duct cancer | 65.5 (19/29) | 34.4 (21/61) | 38.9 (7/18) | 76.3 (87/114) |
| Pancreatic cancer | 41.2 (14/34) | 29.0 (18/62) | 27.3 (3/11) | 46.6 (41/88) |
| Specificity % ( | 100 (17/17) | 97.4 (38/39) | 100 (17/17) | 100 (74/74) |
| PPV % ( | 100 (45/45) | 97.9 (46/47) | 100 (12/12) | 100 (157/157) |
| NPV % ( | 30.4 (17/56) | 27.0 (38/141) | 39.5 (17/43) | 43.8 (74/169) |
| Accuracy % ( | 61.4 (62/101) | 44.7 (84/188) | 52.7 (29/55) | 70.9 (231/326) |
PPV—positive predictive value, NPV—negative predictive value. a—p value compared with scraper cell block group.
Clinical characteristics of the patients diagnosed malignancy by scraper cell block and brush cell block.
| Characteristic of the Patients | Scraper Cell Block ( | Brush Cell Block ( |
|---|---|---|
| Sex, | 28/17 | 8/4 |
| Age (years), median (range) | 76 (53–98) | 64 (51–89) |
| Final diagnosis | ||
| Bile duct cancer, | 19 (42) | 7 (58) |
| Hilar/Distal, | 7/12 | 3/4 |
| Pancreatic cancer, | 14 (31) | 3 (25) |
| Gallbladder cancer, | 6 (13) | 2 (17) |
| Others, | 6 (13) | 0 (0) |
Cases in which immunohistochemistry was helpful for differential diagnosis.
| # | Age | Sex | Final Diagnosis | Immunohistochemical Staining | Excludable | Figure 2 |
|---|---|---|---|---|---|---|
| 1 | 73 | M | Bile duct cancer | CK7(+), CK20(+), CK19(+), CEA(+) | Metastasis from pharyngeal cancer | |
| 2 | 81 | M | Pancreatic cancer | CK7(+), CK20(+), CA19-9(+), MUC1(+), TTF1(−) | Metastasis from lung cancer | |
| 3 | 98 | F | Gallbladder cancer | CK7(+), CK20(−), CA19-9(+) | Metastasis from breast cancer | |
| 4 | 75 | M | Lymph node metastasis | GATA3(+), p40(+) | Bile duct cancer | A |
| 5 | 66 | M | Neuroendocrine tumor | CD56(+), Chromogranin A(+), Synaptophysin(+), CA19-9(−) | Bile duct cancer | B |
| 6 | 53 | M | Pancreatic metastasis from colon cancer | CK7(−), CK20(+), CDX2(+) | Pancreatic cancer | C |
| 7 | 72 | M | Sarcomatoid hepatocellular carcinoma | CKAE1/3(+), Vimentin(+), | Bile duct cancer |
Figure 2Histological findings. Immunohistochemical staining of cell block sections obtained using endoscopic scraper; (A): negative for cytokeratin 7 (CK 7), and positive for CK 20 and caudal-type homeobox 2 (CDX 2); (B): positive for CD56, chromogranin and synaptophysin; (C): positive for GATA3 and p40, and focally positive for CK20.